Volume 23, Number 1Men's HealthContemporary Management of Male HypogonadismAndrew Y SunMale hypogonadism affects up to 40% of men and is becoming more prominent because of increasingly prevalent medical comorbidities. Because various forms of treatment are available today, physicians should discuss drug efficacy and safety while simultaneously ensuring that therapy forms are in alignment with patient preferences. Treatment adherence is critical to sustaining patient health outcomes.HypogonadismHormone replacementtestosterone deficiency
Volume 5, Number 4Review ArticlesAndrogen Replacement Therapy in the Aging MaleTreatment UpdateRandall B MeachamJeremy B MyersDepressionAndrogenTestosteroneHypogonadismErectile dysfunctionAndropauseHormone replacementMale osteoporosisProstatecancerSarcopenia